
Reset all filters
01 5BAYER INC
02 3Bayer AG
03 4Novo Nordisk
04 6Takeda Pharmaceutical
Reset all filters
01 5ANTIHEMOPHILIC FACTOR (RECOMBINANT)
02 13Antihemophilic factor recombinant
Reset all filters
01 10KIT
02 8POWDER FOR SOLUTION
Reset all filters
01 5ADYNOVATE
02 4ESPEROCT
03 3JIVI
04 5KOVALTRY
05 1OBIZUR
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 250UNIT/VIAL
Packaging : 2.5ML
Approval Date :
Application Number : 2451441
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 500UNIT/VIAL
Packaging : 2.5ML
Approval Date :
Application Number : 2451468
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 1000UNIT/VIAL
Packaging : 2.5ML
Approval Date :
Application Number : 2451476
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 2000UNIT/VIAL
Packaging : 5ML
Approval Date :
Application Number : 2451484
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
Brand Name : KOVALTRY
Dosage Form : KIT
Dosage Strength : 3000UNIT/VIAL
Packaging : 5ML
Approval Date :
Application Number : 2451492
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : JIVI
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500UNIT/VIAL
Packaging : 500
Approval Date :
Application Number : 2481766
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ESPEROCT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 500UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2490064
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ESPEROCT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2490072
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ESPEROCT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 2000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2490099
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Antihemophilic factor recombinant
Brand Name : ESPEROCT
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 3000UNIT/VIAL
Packaging :
Approval Date :
Application Number : 2490102
Regulatory Info : Schedule D
Registration Country : Canada